Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Influence of SHIP on the NK Repertoire and Allogeneic Bone Marrow Transplantation
Jia-Wang Wang,1*Julie M. Howson,1*Tomar Ghansah,1*Caroline Desponts,1John M. Ninos,1Sarah L. May,1Kim H. T. Nguyen,1Noriko Toyama-Sorimachi,2William G. Kerr1
Natural killer cell (NK) receptors for major histocompatibility
complex (MHC) class I influence engraftment and graft-versus-tumoreffects after allogeneic bone marrow transplantation. We findthat
SH2-containing inositol phosphatase (SHIP) influences therepertoire of
NK receptors. In adult SHIP/ mice, the NK compartment
is dominated by cells that express twoinhibitory receptors capable of
binding either self or allogeneicMHC ligands. This promiscuous
repertoire has significant functionalconsequences, because
SHIP/ mice fail to reject fully mismatched allogeneic
marrow graftsand show enhanced survival after such transplants. Thus,
SHIPplays an important role in two processes that limit the successof
allogeneic marrow transplantation: graft rejection and
graft-versus-hostdisease.
1 Immunology Program, H. Lee Moffitt
Comprehensive Cancer Center and Research Institute, and Departments of
Interdisciplinary Oncology and Biochemistry, University of South
Florida, Tampa, FL 33612, USA.
2 Department of
Immune Regulation, Tokyo Medical and Dental University, Tokyo 113-8150, Japan.
*
These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail:
kerrw{at}moffitt.usf.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Klas Kärre (15 March 2002) Science295 (5562), 2029.
[DOI: 10.1126/science.1070538] |Summary »|Full Text »|PDF »
REPORTS
Loredana Ruggeri, Marusca Capanni, Elena Urbani, Katia Perruccio, Warren D. Shlomchik, Antonella Tosti, Sabrina Posati, Daniela Rogaia, Francesco Frassoni, Franco Aversa, Massimo F. Martelli, and Andrea Velardi (15 March 2002) Science295 (5562), 2097.
[DOI: 10.1126/science.1068440] |Abstract »|Full Text »|PDF »|Supplemental Data »
Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells.
R. Trotta, L. Chen, S. Costinean, S. Josyula, B. L. Mundy-Bosse, D. Ciarlariello, C. Mao, E. L. Briercheck, K. K. McConnell, A. Mishra, et al. (2013)
Blood
121, 3126-3134
|Abstract »|Full Text »|PDF »
Ly49Q Positively Regulates Type I IFN Production by Plasmacytoid Dendritic Cells in an Immunoreceptor Tyrosine-Based Inhibitory Motif-Dependent Manner.
M. M. A. Rahim, L.-H. Tai, A. D. Troke, A. B. Mahmoud, E. Abou-Samra, J. G. Roy, A. Mottashed, N. Ault, C. Corbeil, M.-L. Goulet, et al. (2013)
J. Immunol.
190, 3994-4004
|Abstract »|Full Text »|PDF »
Inositol tetrakisphosphate limits NK cell effector functions by controlling PI3K signaling.
K. Sauer, E. Park, S. Siegemund, A. R. French, J. A. Wahle, L. Sternberg, S. Rigaud, A. H. Jonsson, W. M. Yokoyama, and Y. H. Huang (2013)
Blood
121, 286-297
|Abstract »|Full Text »|PDF »
Quorum Sensing Contributes to Activated IgM-Secreting B Cell Homeostasis.
C. Montaudouin, M. Anson, Y. Hao, S. V. Duncker, T. Fernandez, E. Gaudin, M. Ehrenstein, W. G. Kerr, J.-H. Colle, P. Bruhns, et al. (2013)
J. Immunol.
190, 106-114
|Abstract »|Full Text »|PDF »
Mouse natural killer cell development and maturation are differentially regulated by SHIP-1.
C. Banh, S. M. S. Miah, W. G. Kerr, and L. Brossay (2012)
Blood
120, 4583-4590
|Abstract »|Full Text »|PDF »
Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies.
J. G. Foster, M. D. Blunt, E. Carter, and S. G. Ward (2012)
Pharmacol. Rev.
64, 1027-1054
|Abstract »|Full Text »|PDF »
An ENU-induced mouse mutant of SHIP1 reveals a critical role of the stem cell isoform for suppression of macrophage activation.
N.-Y. N. Nguyen, M. J. Maxwell, L. M. Ooms, E. M. Davies, A. A. Hilton, J. E. Collinge, D. J. Hilton, B. T. Kile, C. A. Mitchell, M. L. Hibbs, et al. (2011)
Blood
117, 5362-5371
|Abstract »|Full Text »|PDF »
W. G. Kerr, M.-Y. Park, M. Maubert, and R. W. Engelman (2011)
Gut
60, 177-188
|Abstract »|Full Text »|PDF »
SHIP Represses Th2 Skewing by Inhibiting IL-4 Production from Basophils.
E. Kuroda, F. Antignano, V. W. Ho, M. R. Hughes, J. Ruschmann, V. Lam, T. Kawakami, W. G. Kerr, K. M. McNagny, L. M. Sly, et al. (2011)
J. Immunol.
186, 323-332
|Abstract »|Full Text »|PDF »
SHIP Influences Signals from CD48 and MHC Class I Ligands That Regulate NK Cell Homeostasis, Effector Function, and Repertoire Formation.
N. R. Fortenbery, K. H. T. Paraiso, M. Taniguchi, C. Brooks, L. Ibrahim, and W. G. Kerr (2010)
J. Immunol.
184, 5065-5074
|Abstract »|Full Text »|PDF »
SHIP1 Inhibition Increases Immunoregulatory Capacity and Triggers Apoptosis of Hematopoietic Cancer Cells.
R. Brooks, G. M. Fuhler, S. Iyer, M. J. Smith, M.-Y. Park, K. H. T. Paraiso, R. W. Engelman, and W. G. Kerr (2010)
J. Immunol.
184, 3582-3589
|Abstract »|Full Text »|PDF »
SHIP limits immunoregulatory capacity in the T-cell compartment.
M. M. Collazo, D. Wood, K. H. T. Paraiso, E. Lund, R. W. Engelman, C.-T. Le, D. Stauch, K. Kotsch, and W. G. Kerr (2009)
Blood
113, 2934-2944
|Abstract »|Full Text »|PDF »
SHIP is required for a functional hematopoietic stem cell niche.
A. L. Hazen, M. J. Smith, C. Desponts, O. Winter, K. Moser, and W. G. Kerr (2009)
Blood
113, 2924-2933
|Abstract »|Full Text »|PDF »
The Inositol Phosphatase SHIP Controls Salmonella enterica Serovar Typhimurium Infection In Vivo.
J. L. Bishop, L. M. Sly, G. Krystal, and B. B. Finlay (2008)
Infect. Immun.
76, 2913-2922
|Abstract »|Full Text »|PDF »
Inappropriate Recruitment and Activity by the Src Homology Region 2 Domain-Containing Phosphatase 1 (SHP1) Is Responsible for Receptor Dominance in the SHIP-Deficient NK Cell.
J. A. Wahle, K. H. T. Paraiso, R. D. Kendig, H. R. Lawrence, L. Chen, J. Wu, and W. G. Kerr (2007)
J. Immunol.
179, 8009-8015
|Abstract »|Full Text »|PDF »
The Pten/PI3K pathway governs the homeostasis of V{alpha}14iNKT cells.
H. Kishimoto, T. Ohteki, N. Yajima, K. Kawahara, M. Natsui, S. Kawarasaki, K. Hamada, Y. Horie, Y. Kubo, S. Arase, et al. (2007)
Blood
109, 3316-3324
|Abstract »|Full Text »|PDF »
KLRG1 binds cadherins and preferentially associates with SHIP-1.
M. S. Tessmer, C. Fugere, F. Stevenaert, O. V. Naidenko, H. J. Chong, G. Leclercq, and L. Brossay (2007)
Int. Immunol.
19, 391-400
|Abstract »|Full Text »|PDF »
K. H. T. Paraiso, T. Ghansah, A. Costello, R. W. Engelman, and W. G. Kerr (2007)
J. Immunol.
178, 2893-2900
|Abstract »|Full Text »|PDF »
Ly49B Is Expressed on Multiple Subpopulations of Myeloid Cells.
F. Gays, J. G. Aust, D. M. Reid, J. Falconer, N. Toyama-Sorimachi, P. R. Taylor, and C. G. Brooks (2006)
J. Immunol.
177, 5840-5851
|Abstract »|Full Text »|PDF »
Differential and Nonredundant Roles of Phospholipase C{gamma}2 and Phospholipase C{gamma}1 in the Terminal Maturation of NK Cells.
J. Regunathan, Y. Chen, S. Kutlesa, X. Dai, L. Bai, R. Wen, D. Wang, and S. Malarkannan (2006)
J. Immunol.
177, 5365-5376
|Abstract »|Full Text »|PDF »
Cutting Edge: Dominance by an MHC-Independent Inhibitory Receptor Compromises NK Killing of Complex Targets..
J. A. Wahle, K. H. T. Paraiso, A. L. Costello, E. L. Goll, C. L. Sentman, and W. G. Kerr (2006)
J. Immunol.
176, 7165-7169
|Abstract »|Full Text »|PDF »
SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation.
C. Desponts, A. L. Hazen, K. H. T. Paraiso, and W. G. Kerr (2006)
Blood
107, 4338-4345
|Abstract »|Full Text »|PDF »
IFN-{gamma} Acts on T Cells to Induce NK Cell Mobilization and Accumulation in Target Organs..
O. Wald, I. D. Weiss, H. Wald, H. Shoham, Y. Bar-Shavit, K. Beider, E. Galun, L. Weiss, L. Flaishon, I. Shachar, et al. (2006)
J. Immunol.
176, 4716-4729
|Abstract »|Full Text »|PDF »
Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).
IFN Regulatory Factor-2 Deficiency Revealed a Novel Checkpoint Critical for the Generation of Peripheral NK Cells.
S. Taki, S. Nakajima, E. Ichikawa, T. Saito, and S. Hida (2005)
J. Immunol.
174, 6005-6012
|Abstract »|Full Text »|PDF »
Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation.
R. Trotta, R. Parihar, J. Yu, B. Becknell, J. Allard II, J. Wen, W. Ding, H. Mao, S. Tridandapani, W. E. Carson, et al. (2005)
Blood
105, 3011-3018
|Abstract »|Full Text »|PDF »
Expansion of Myeloid Suppressor Cells in SHIP-Deficient Mice Represses Allogeneic T Cell Responses.
T. Ghansah, K. H. T. Paraiso, S. Highfill, C. Desponts, S. May, J. K. McIntosh, J.-W. Wang, J. Ninos, J. Brayer, F. Cheng, et al. (2004)
J. Immunol.
173, 7324-7330
|Abstract »|Full Text »|PDF »
Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice.
K. Beider, A. Nagler, O. Wald, S. Franitza, M. Dagan-Berger, H. Wald, H. Giladi, S. Brocke, J. Hanna, O. Mandelboim, et al. (2003)
Blood
102, 1951-1958
|Abstract »|Full Text »|PDF »
Macrophages Control the Retention and Trafficking of B Lymphocytes in the Splenic Marginal Zone.
M. C.I. Karlsson, R. Guinamard, S. Bolland, M. Sankala, R. M. Steinman, and J. V. Ravetch (2003)
J. Exp. Med.
198, 333-340
|Abstract »|Full Text »|PDF »
SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells.
R. Galandrini, I. Tassi, G. Mattia, L. Lenti, M. Piccoli, L. Frati, and A. Santoni (2002)
Blood
100, 4581-4589
|Abstract »|Full Text »|PDF »